Alcon Inc. logo

Alcon Inc.

ALC | NYSE
Chart Builder DCF Calculator
$64.87
-$0.17 (-0.26%)
At close: Sep 21, 2026, 4:00 PM ET
$64.87
$0 (0.00%)
After-hours: Sep 21, 2026, 5:31 PM ET

Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Key Executives

Name Position
David J. Endicott Chief Executive Officer & Director
Ian Bell Senior Vice President & Chief Operating Officer
Timothy C. Stonesifer Senior Vice President & Chief Financial Officer
Daniel Cravens Vice President of Investor Relations
Franck Leveiller SVP of Global Research & Development and Chief Scientific Officer
Kimberly Martin Senior VP and Chief HR & Corporate Communications
Leon Sergio Duplan Fraustro Senior Vice President & President of Americas
Margaret Buckley Chief Accounting Officer
Muru Murugappan Senior Vice President and Chief Information & Transformation Officer
Royce R. Bedward Senior Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Aug 10, 2026 6-K Filing
May 15, 2026 SD Filing
May 05, 2026 6-K Filing
Apr 02, 2026 6-K Filing
Feb 24, 2026 6-K Filing
Feb 24, 2026 20-F Filing
Feb 24, 2026 6-K Filing
Jan 07, 2026 6-K Filing
Dec 09, 2025 DFAN14A Filing
Nov 12, 2025 6-K Filing
View All SEC Filings
Alcon Inc.
Alcon Inc. logo
Country Switzerland
IPO Date Apr 8, 2019
Industry Medical - Specialties
Sector Healthcare
Employees 25,000
CEO David J. Endicott

Contact Details

Chemin de Blandonnet 8 Geneva, GE 1214 Switzerland

Stock Details

Ticker Symbol ALC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001167379
CUSIP Number H01301128
ISIN Number CH0432492467
SIC Code 3851

© 2026 bestshares.com. All rights reserved.